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Cutaneous pseudolymphoma is a heterogeneous group of benign reactive T-cell or B-cell lymphoproliferative 
process, which clinically and histologically simulates cutaneous lymphomas. A few cases of pseudolymphomas, 
showing atypical clinical forms, have been reported previously in the literature, but are rare. A 23-year old male was 
presented with 4-year duration of cutaneous lesion on the right retroauricular area. On physical examination, about 
a 2×1 cm sized erythematous, elevated and protruded, firm nodule was seen. The cutaneous lesion resembled the 
appearance of keloid, but the patient did not have any obvious history of trauma. A punch biopsy was performed, 
and histologically, the lesion was diagnosed as cutaneous pseudolymphoma. After a single treatment of triamcinolone 
acetonide intralesional injection, the lesion was almost cleared. In this report, we present an interesting case of 
pseudolymphoma with a clinical finding resembling the appearance of keloid in a patient without any traumatic 
history. (Korean J Dermatol 2012;50(11):1006∼1008)
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INTRODUCTION
Cutaneous pseudolymphoma, first described by Kaposi in 
18911, is a heterogeneous group of benign reactive T-cell or 
B-cell lymphoproliferative process, which can clinically and 
histologically simulate cutaneous lymphomas2. In this report, 
we present a case of cutaneous pseudolymphoma that had 
an atypical appearance, mimicking the clinical morphology 
of keloid. 
CASE REPORT
A 13-year old male was presented with 4-year duration of 
cutaneous lesion on the right retroauricular area. On phy-
sical examination, about a 2×1 cm sized well-demarcated 
erythematous to brownish, elevated and protruded, firm 
nodule was seen, and slight hyperesthesia was felt on the 
lesion. The patient did not have any medical or familial 
history. According to its firm, rubbery and erythematous 
nodular appearance accompanied with pain and itching, the 
cutaneous lesion resembled the clinical manifestation of 
keloid, but he did not have any obvious history of trauma 
or any previous cutaneous diseases on the site. A punch 
biopsy was performed, and histologically, the lesion showed 
diffuse dermal lymphoid cell infiltration with lymphoid fo-
llicle formation with positive in the reactive B- and T-lym-
phocytes by CD20 and CD3 immunohistochemical staining 
(Fig. 1). BCL-2 was not expressed in the germinal center. 
According to the clinical and histologic findings, the patient 
was diagnosed as pseudolymphoma, and after a single 
treatment of 20 mg/ml triamcinolone acetonide intralesional 
injection, the lesion was almost cleared (Fig. 2). Two 
further injections were done, and the lesion was resolved 
without any evidence of recurrence for six months.
DISCUSSION
The term, ‘pseudolymphoma’, only implies the lymphocytic 
infiltration in response to the various stimuli without any in-
formation about the cause3. In most cases, cutaneous pseudo-
lymphomas are idiopathic, but foreign antigens, such as tat-
too dyes, vaccinations, arthropod venoms, acupuncture, and 
infections with Borrelia burgdorferi, varicella-zoster virus, 
human immunodeficiency virus, and also trauma are well 
known causes. Medications, including phenytoin, carbamaze-
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Fig. 2. Clinical appearance of the 
cutaneous pseudolymphoma at ini-
tial visit (A) and 1 month after a 
single injection of intralesional co-
rticosteroid (B)
Fig. 1. Histologic findings shows 
diffuse dermal lymphoid cell infil-
tration with lymphoid follicle for-
mation. (A) H&E ×40, (B) CD3 
×100, (C) CD20 ×100
pine, captopril, atenolol, verapamil, allopurinol, penicillin, 
dapsone, and etc. have also been reported to induce cuta-
neous pseudolymphomas3,4.
The cutaneous lesions of pseudolymphoma commonly 
present as an erythematous to brownish or violaceous soli-
tary nodule, but it also commonly appears as single or mul-
tiple papules or infiltrated plaques. There has been some 
prior reports describing clinically unusual forms of cuta-
neous pseudolymphomas, appearing as ulcerating facial mass-
es5, for example, but are rare. To our knowledge, cutaneous 
pseudolymphoma mimicking the clinical appearance of ke-
loid has never been reported.
Different treatment options for cutaneous pseudolympho-
ma include antibiotics, intralesional or systemic cortico-
steroids, excision, cryosurgery, and local radiotherapy. In wide-
spread cases, antimalarials and immune suppressants have al-
so been successfully used3,4. Although spontaneous resolution 
is observed in some cases, the clinical course of cutaneous 
psudolymphoma widely varies, requiring proper treatment in 
many cases. Therefore, the treatment should be chosen con-
sidering various factors, such as the extent of disease and its 
biologic behavior, anatomical site, and the patients need. In 
our patient, as he presented with a single, localized cuta-
neous lesion, intralesional corticosteroid injection was at-
tempted as the first choice resulting in successful clinical 
outcome. 
1008 대한피부과학회지: 제 50 권 제 11 호 2012년
We have experienced an interesting case of cutaneous 
pseudolymphoma with an unusual clinical appearance, which 
responded well to intralesional corticosteroid injection. Our 
case suggests dermatologists to be aware that cutaneous 
pseudolymphomas can even mimic the appearance of keloid 
clinically. 
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